Gyroscope Therapeutics
Claire Harris is a world-renowned scientist who has dedicated their life to researching and developing new treatments for a variety of diseases. Claire currently serves on the Scientific Advisory Board for Gyroscope Therapeutics, and has previously held positions at INTERNATIONAL COMPLEMENT SOCIETY, Newcastle University, GlaxoSmithKline, and Cardiff University. Claire Harris has been instrumental in developing new therapies for diseases such as cancer and Alzheimer's, and their work has helped to improve the lives of millions of people around the world.
Claire Harris has a PhD in Immunology from the University of Cambridge and a BSc in Biochemistry from the University of York.
This person is not in the org chart
This person is not in any offices
Gyroscope Therapeutics
Gyroscope Therapeutics is a clinical-stage retinal gene therapy company developing gene therapy beyond rare diseases to treat a leading cause of blindness, dry age-related macular degeneration (AMD).